C12N 2760/18162
By genetic engineering
Official title: by genetic engineering
C12N2760/18162 (By genetic engineering) appears on 1 US grants and 4 published applications in this corpus.
Search patents in C12N- Granted patents
- 1
- Published applications
- 4
- Assignees
- 4
- Inventors
- 18
- Latest grant
- 8 May 2012
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 1 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Virus attenuation30 Apr 2026US 2026/0115273 A1University of Lancaster
- Newcastle Disease Virus with Improved Heat Resistance, and Newcastle Disease Virus Vaccine Comprising Same5 Mar 2026US 2026/0061047 A1Biopoa, Inc.
- Engineered newcastle disease virus vector and uses thereof15 Dec 2022US 2022/0396809 A1University of Guelph
- Attenuated recombinant newcastle disease virus and vaccine containing the same22 Jul 2010US 2010/0183664 A1KBNP, Inc.
Most cited
By later US patents